References
- Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75:787–809.
- Naksuriya O, Okonogi S, Schiffelers RM, et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35:3365–3383.
- Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma. Anti-Cancer Drugs. 2012;23:597–605.
- Sandur SK, Pandey MK, Sung B, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765–1773.
- Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. CPD. 2013;19:1994.
- Aditya N, Shim M, Lee I, et al. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J Agric Food Chem. 2013;61:1878–1883.
- Aggarwal BB. Prostate cancer and curcumin: add spice to your life. Cancer Biol Ther. 2008;7:1436–1440.
- Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. ACAMC. 2006;6:259–270.
- Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–818.
- Popat A, Karmakar S, Jambhrunkar S, et al. Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity. Colloids Surf B Biointerfaces. 2014;117:520–527.
- Wilken R, Veena MS, Wang MB, et al. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:1–19.
- Friedman L, Lin L, Ball S, et al. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. Anti-Cancer Drugs. 2009;20:444.
- Adlerova L, Bartoskova A, Faldyna M. Lactoferrin: a review. Veterinarni Medicina 2008;53:457–468.
- Baumrucker CR, Schanbacher F, Shang Y, et al. Lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells. Domestic Animal Endocrinol. 2006;30:289–303.
- Manju S, Sreenivasan K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interface Sci. 2011;359:318–325.
- Kim TH, Jiang HH, Youn YS, et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm. 2011;403:285–291.
- Dosio F, Brusa P, Crosasso P, et al. Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate. J Control Release. 1997;47:293–304.
- Mongelli N, Angelucci F, Pesenti E, Suarato A, Biasoli G. Polymer-bound paclitaxel derivatives. Google Patents; 1994.
- Iyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discovery Today. 2006;11:812–818.
- Kamalinia G, Khodagholi F, Atyabi F, et al. Enhanced brain delivery of deferasirox–lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies. Mol Pharmaceutics. 2013;10:4418–4431.
- Tanaka T, kaneo Y, miyashita M. Synthesis of transferrin-mitomycin C conjugate as a receptor-mediated drug targeting system. Biol Pharm Bull. 1996;19:774–777.
- D'Souza AA, Devarajan PV. Rapid and simultaneous hplc analysis of curcumin and its metabolite tetrahydrocurcumin from plasma and liver homogenates. J Liquid Chromatogr Related Technol. 2013;36:1788–1801.
- Rath A, Glibowicka M, Nadeau VG, et al. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci 2009;106:1760–1765.
- Sambrook J, Russell David W. Molecular cloning: a laboratory manual. Vol. 3: Cold Spring Harbor Laboratory Press; 1989.
- Whitesides GM, Grzybowski B. Self-assembly at all scales. Science. 2002;295:2418–2421.